Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cell Exosome Treatment of Congenital Myasthenic Syndrome

NCT07226726 is registered in ClinicalTrials.gov with The Foundation for Orthopaedics and Regenerative Medicine as lead sponsor.

NCT NCT07226726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07226726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cell Exosome Treatment of Congenital Myasthenic Syndrome
Lead sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Phase
Phase 1
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2028
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

congenital myasthenic syndrome